Advertisement
Advertisement

KRRO

KRRO logo

Korro Bio, Inc. Common Stock

12.65
USD
Sponsored
-1.12
-8.10%
Jun 25, 11:51 UTC -4
Open

KRRO Earnings Reports

Positive Surprise Ratio

KRRO beat 15 of 27 last estimates.

56%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$218.57K
/
-$1.29
Implied change from Q1 26 (Revenue/ EPS)
--
/
-23.67%
Implied change from Q2 25 (Revenue/ EPS)
-85.03%
/
-52.92%

Korro Bio, Inc. Common Stock earnings per share and revenue

On May 07, 2026, KRRO reported earnings of -1.69 USD per share (EPS) for Q1 26, beating the estimate of -1.87 USD, resulting in a 10.05% surprise. Revenue reached --, compared to an expected 625.67 thousand, with a -100.00% difference. The market reacted with a -3.37% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -1.29 USD, with revenue projected to reach 218.57 thousand USD, implying an decrease of -23.67% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, Korro Bio, Inc. Common Stock reported EPS of -$1.69, beating estimates by 10.05%, and revenue of $0.00, -100% below expectations.
The stock price moved down -3.37%, changed from $13.34 before the earnings release to $12.89 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 9 analysts, Korro Bio, Inc. Common Stock is expected to report EPS of -$1.29 and revenue of $218.57K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement